Showing results 1 to 8 of 8
Title | Author(s) | Issue Date | |
---|---|---|---|
A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602) Journal:Journal of Thoracic Oncology | 2010 | ||
2013 | |||
An Interim Report Of CALGB 150607: Expression And Mutational Status Of c-MET, HGF, EGFR, KRAS, p53, c-CBL, And E-cadherin In Resected Lung Adenocarcinoma Specimens Proceeding/Conference:Journal of Thoracic Oncology | 2012 | ||
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and leukemia group B 30601): A brief report Journal:Journal of Thoracic Oncology | 2012 | ||
Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304) Journal:Journal of Thoracic Oncology | 2010 | ||
2013 | |||
2011 | |||
2017 |